New York: Novo Nordisk has secured the US Food and Drug Administration (US FDA)’s approval for the pill version of…
Browsing: Novo Nordisk
New Delhi: The blockbuster weight loss drug Ozempic is all set to get an Indian generic variant, with the Delhi…
New York: A new player has emerged in the almost $300 billion weight loss market. Following Ozempic’s exploding popularity as…
New Delhi: Pfizer just pulled off a $10 billion masterstroke. After a week of boardroom chaos and regulatory warnings, the…
Mumbai: The widely popular weight loss drug, Ozempic, has been approved by the Central Drugs Standard Control Organisation (CDSCO) for…
